Adherence measured by Medication event monitoring system in TPiple Antihypertensive Combination: single- versus two-pill regimen

Trial Profile

Adherence measured by Medication event monitoring system in TPiple Antihypertensive Combination: single- versus two-pill regimen

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Feb 2017

At a glance

  • Drugs Olmesartan medoxomil/amlodipine/hydrochlorothiazide (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms AMTRAC
  • Most Recent Events

    • 02 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 07 Mar 2016 New trial record
    • 01 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ISRCTN: Current Controlled Trials
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top